GEVONasdaqIndustrial Organic ChemicalsFiscal year ends December 31

Gevo, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$1.13−0.04 (-3.42%)

Close on Oct 19, 2026

Market cap: $267.87M
P/E (TTM): –
Dividend yield: –

Dividends

Gevo has not reported a dividend

No dividend per share appears in Gevo's annual filings since fiscal 2010.

Where these numbers come from

Parsed from the XBRL in Gevo's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20 reverse split on Aug 8, 2018
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is GEVO.

Revenue growth121.4% · median 1.1%

Gross margin47.3% · median 8.9%

Operating margin-102.8% · median -13.0%

Net margin-119.9% · median -7.2%

Company	Revenue	Growth
ALTO	$943.33M	+1.1%
REX	$658.58M	+1.3%
AMTX	$219.82M	-1.7%
GEVO	$177.51M	+121.4%
FF	$153.21M	-7.6%
LNZA	$58.31M	+43.8%

Company

Next earnings (est.): Nov 9, 2026, during market hours
Exchange: Nasdaq
Industry: Industrial Organic Chemicals
Fiscal year ends: December 31
Employees: 151
Held by institutions: 37.2%
Auditor: Deloitte & Touche LLP
SEC CIK: 1392380

Advertisement
300 × 250